The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2425339122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Bowen Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138. Hauptthemen laut MEDLINE: Trophoblasts, HLA-G Antigens, DNA-Binding Proteins, Transcription Factors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Maternal–fetal immune tolerance guarantees a successful pregnancy throughout gestation. HLA-G, a nonclassical human leukocyte antigen (HLA) molecule exclusively expressed in extravillous trophoblasts (EVT), is a crucial factor in establishing maternal–fetal immune tolerance by interacting with inhibitory receptors on various maternal immune cells residing in the uterus. While trophoblast-specific cis-regulatory elements impacting HLA-G transcription have been described, the identity of trans-acting factors controlling HLA-G expression in EVT remains poorly understood. Utilizing a genome-wide CRISPR-Cas9 knockout screen, we find that the WNT signaling pathway negatively regulates HLA-G expression in EVT. In addition, we identified two trophoblast-specific transcription factors, TEAD1 and TEAD3, required for HLA-G transcription in EVT in a Yes-associated protein-independent manner. Altogether, we systematically elucidated essential genes and pathways underlying HLA-G expression in EVT, shedding light on the mechanisms of maternal–fetal tolerance and potentially providing insights into controlling HLA-G expression beyond EVT to protect allogeneic cells from immune rejection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
- Program in Cellular and Molecular Medicine Boston Children's Hospital, Boston, MA 02115.
- Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
- Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425.
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425.
- Cancer Biology and Immunology Program, Hollings Cancer Center, Charleston, SC 29425.
ORCID-Profile: Judy Lieberman, Jack L Strominger
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Gu, B., Ferreira, L. M. R., Herrera, S., Brown, L., Lieberman, J., Sherwood, R. I., Meissner, T. B., & Strominger, J. L. (2025). The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2425339122
Vancouver
Gu B, Ferreira LMR, Herrera S, Brown L, Lieberman J, Sherwood RI, et al. The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2425339122
BibTeX
@article{Gu2025,
author = {Gu, Bowen and Ferreira, Leonardo M R and Herrera, Sebastian and Brown, Lara and Lieberman, Judy and Sherwood, Richard I and Meissner, Torsten B and Strominger, Jack L},
title = {The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2425339122}
}
EUVIMED